Pyrukynd 50mg Tablets
Overview
What is this medicine?
How to Use This Medicine
To use this medication correctly, follow your doctor's instructions and read all the information provided. Take your medication as directed, with or without food, and swallow the tablets whole. Do not chew, break, crush, or dissolve them. Continue taking your medication as prescribed by your doctor or healthcare provider, even if you start feeling well.
Storing and Disposing of Your Medication
Store your medication at room temperature in a dry place, avoiding bathrooms. Keep the blister wallets in their original carton until you are ready to use them. Always keep your medications in a safe location, out of the reach of children and pets.
Missing a Dose
If you miss a dose, take it as soon as you remember. However, if you miss a dose by more than 4 hours, skip the missed dose and resume your regular schedule. Do not take two doses at the same time or take extra doses to make up for the missed one.
Lifestyle & Tips
- Take Pyrukynd exactly as prescribed by your doctor, usually twice a day.
- You can take Pyrukynd with or without food.
- Do not stop taking Pyrukynd without talking to your doctor.
- Inform your doctor about all other medications, supplements, and herbal products you are taking, as many can interact with Pyrukynd.
Available Forms & Alternatives
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek immediate medical attention:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of high blood pressure, including:
+ Severe headache or dizziness
+ Passing out
+ Changes in eyesight
Fast or abnormal heartbeat
Breast pain
Abnormal sensations, such as burning, numbness, or tingling
Signs of liver problems, which may include:
+ Dark urine
+ Tiredness
+ Decreased appetite
+ Upset stomach or stomach pain
+ Light-colored stools
+ Vomiting
+ Yellow skin or eyes (jaundice)
Note: People taking higher doses of this medication for other health conditions have an increased risk of liver problems, especially during the first 6 months of treatment.
Other Possible Side Effects
Like all medications, this drug can cause side effects. While many people may not experience any side effects or only minor ones, it's essential to discuss any concerns with your doctor. If you experience any of the following side effects or any other symptoms that bother you or do not go away, contact your doctor:
Back pain
Joint pain
Stomach pain or diarrhea
Flushing
Mouth or throat pain or irritation
Constipation
Dry mouth
Dry lips
This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Increased fatigue or weakness
- Yellowing of the skin or eyes (jaundice)
- Dark urine
- Unexplained nausea, vomiting, or abdominal pain
- Unusual bleeding or bruising
- Signs of infection (fever, chills)
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
If you have liver disease, as this may affect the use of this medication.
* Any medications you are currently taking, including prescription and over-the-counter (OTC) drugs, natural products, and vitamins. This is crucial because certain medications, such as those used to treat HIV, infections, seizures, and other conditions, should not be taken with this drug. There are many potential drug interactions, so it is vital to disclose all medications you are taking.
To ensure your safety, it is crucial to provide your doctor and pharmacist with a comprehensive list of all your medications, including prescription and OTC drugs, natural products, and vitamins, as well as any health problems you have. This will enable them to verify that it is safe for you to take this medication with your other medications and health conditions. Never start, stop, or change the dose of any medication without first consulting your doctor.
Precautions & Cautions
To minimize the risk of hemolytic anemia (red blood cell breakdown), do not abruptly discontinue this medication. If you need to stop taking this drug, your doctor will instruct you on how to gradually taper off the dosage. Immediately report any symptoms of hemolysis to your doctor, such as jaundice (yellow skin or eyes), dark urine, dizziness, confusion, fatigue, or shortness of breath.
Avoid consuming grapefruit and grapefruit juice while taking this medication, as it may interact with the drug. Additionally, be aware that this medication can cause elevated triglyceride levels. If you have a history of hypertriglyceridemia, inform your doctor.
In men, this medication may decrease levels of the reproductive hormones estrone and estradiol. If you have concerns or questions, discuss them with your doctor.
Women taking this medication should be aware that birth control pills and other hormone-based contraceptives may be less effective. To prevent pregnancy, use an additional form of birth control, such as a condom, while taking this drug.
If you are pregnant, plan to become pregnant, or are breastfeeding, consult your doctor to discuss the potential benefits and risks of this medication to you and your baby.
Overdose Information
Overdose Symptoms:
- Symptoms of overdose are not well established, but may include exaggerated adverse effects.
What to Do:
In case of suspected overdose, contact a poison control center immediately (1-800-222-1222) or seek emergency medical attention.
Drug Interactions
Contraindicated Interactions
- Strong CYP3A inducers (e.g., rifampin, carbamazepine, phenytoin, St. John's Wort): May significantly decrease mitapivat exposure, leading to loss of efficacy.
Major Interactions
- Moderate CYP3A inducers (e.g., efavirenz, bosentan): May decrease mitapivat exposure, leading to loss of efficacy. Avoid coadministration.
- Strong CYP3A inhibitors (e.g., ketoconazole, clarithromycin, ritonavir): May increase mitapivat exposure. Reduce mitapivat dose.
- Moderate CYP3A inhibitors (e.g., fluconazole, diltiazem): May increase mitapivat exposure. Reduce mitapivat dose.
Moderate Interactions
- P-glycoprotein (P-gp) substrates (e.g., digoxin, dabigatran): Mitapivat is a P-gp inhibitor; may increase concentrations of P-gp substrates. Monitor and adjust dose of P-gp substrate as needed.
- Breast Cancer Resistance Protein (BCRP) substrates (e.g., rosuvastatin): Mitapivat is a BCRP inhibitor; may increase concentrations of BCRP substrates. Monitor and adjust dose of BCRP substrate as needed.
Monitoring
Baseline Monitoring
Rationale: To establish baseline hematologic parameters and assess severity of anemia/hemolysis.
Timing: Prior to initiation of therapy.
Rationale: To establish baseline liver function, as dose adjustments are needed for hepatic impairment.
Timing: Prior to initiation of therapy.
Routine Monitoring
Frequency: Periodically (e.g., every 4-8 weeks during titration, then every 3-6 months or as clinically indicated)
Target: Improvement in hemoglobin, reduction in reticulocyte count, reduction in indirect bilirubin.
Action Threshold: Lack of response or worsening parameters may indicate need for dose adjustment or re-evaluation.
Frequency: Periodically (e.g., every 3-6 months or as clinically indicated)
Target: Within normal limits or stable from baseline.
Action Threshold: Significant elevations may require dose adjustment or discontinuation.
Symptom Monitoring
- Signs and symptoms of worsening anemia (e.g., increased fatigue, pallor, shortness of breath, dizziness)
- Signs and symptoms of hemolysis (e.g., jaundice, dark urine, scleral icterus)
- Signs and symptoms of liver dysfunction (e.g., unexplained nausea, vomiting, abdominal pain, dark urine, yellowing of skin or eyes)
Special Patient Groups
Pregnancy
Based on animal studies, Pyrukynd may cause fetal harm. There are no adequate and well-controlled studies in pregnant women. Discuss potential risks and benefits with your healthcare provider if you are pregnant or plan to become pregnant.
Trimester-Specific Risks:
Lactation
It is unknown if mitapivat is excreted in human milk. Due to the potential for serious adverse reactions in a breastfed infant, breastfeeding is not recommended during treatment with Pyrukynd and for at least 14 days after the last dose.
Pediatric Use
Safety and effectiveness have not been established in pediatric patients.
Geriatric Use
No overall differences in safety or effectiveness were observed between elderly patients and younger adult patients. No specific dose adjustment is required based on age alone.
Clinical Information
Clinical Pearls
- Pyrukynd is the first and only FDA-approved oral therapy for pyruvate kinase deficiency.
- Dose titration is crucial for optimizing response and managing tolerability.
- Patients should be educated on the importance of consistent dosing and potential drug interactions, especially with CYP3A inducers/inhibitors.
- Regular monitoring of hematologic parameters and liver function is essential.
Alternative Therapies
- Blood transfusions (supportive care for anemia)
- Splenectomy (surgical intervention for severe hemolysis)
- Iron chelation therapy (for transfusion-dependent patients)